Thermo Fisher General Counsel Granted Equity Award
THERMO FISHER SCIENTIFIC INC.
Subscribe to track TMO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Thermo Fisher General Counsel Granted Equity Award
Company: Thermo Fisher Scientific Inc. (TMO) Form: 4 | Filed: 2026-02-27 Significance: Low
Insider: Shropshire Thomas B Jr. Title: SVP and General Counsel | Relationship: Officer
Transaction: • Type: Grant (Award) • Shares: 978 (Common Stock) • Price: $0.00 • Value: $0 (Compensation Grant) • Owned After: 6,057
Key Insight: Routine annual executive compensation grant involving restricted stock and options. No open market activity.
Market Context: Transaction represents negligible dilution (<0.001% of outstanding shares) for this $191B market cap company.
Comprehensive Analysis
SEC Filing Analysis: Thermo Fisher Scientific Inc. (TMO)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Routine annual executive compensation grant; no open market buying or selling detected.
- Market Impact: Neutral - Standard corporate governance procedure.
Company Information
| Field | Value |
|---|---|
| Company | Thermo Fisher Scientific Inc. |
| Ticker Symbol | TMO |
| CIK | 0000097745 |
| Market Cap | $191.96B |
Insider Information
| Field | Value |
|---|---|
| Name | Shropshire Thomas B Jr. |
| CIK | 0002070785 |
| Title/Position | SVP and General Counsel |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-02-25 |
| Transaction Code | A (Grant/Award) |
| Security Type | Common Stock & Options |
| Shares Involved | 978 (Stock) + 4,281 (Options) |
| Price Per Share | $0.00 (Grant) |
| Total Value | $0 (Compensation) |
| Shares Owned After | 6,057 (Direct) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 (Grant) |
| % of Market Cap | 0.00% |
| Shares Transacted | 5,259 (Combined) |
| % of Shares Outstanding | ~0.0014% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a large-cap entity ($191.96B), this equity award is standard operational compensation.
- Dilution Impact: With 375.71M shares outstanding, the issuance of ~5,200 shares/options creates virtually zero dilution.
- Transaction Significance: The transaction is an award (Code A), not a purchase or sale, indicating alignment of insider interests with shareholders via long-term vesting (options expire in 2036).
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Routine compensation grants do not signal market sentiment or insider confidence in the same way open market purchases do.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Details: The reporting person received 978 shares of Common Stock and 4,281 Stock Options (exercisable at $513.68).
- Vesting: The options vest in four equal annual installments beginning February 28, 2027.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.